Why Alphabet Inc. (GOOG) is One of the Best Stocks to Buy Now for Long Term Growth
Alphabet Inc. (NASDAQ:GOOG) is one of the best stocks to buy now for long term growth. Truist lifted the price target on Alphabet Inc.
Insider Monkey Blog
Long Cast Advisors’ Views in Research Solutions’ (RSSS) Insights on Business Resilience and Innovation
Long Cast Advisors, an independent registered investment adviser, released its Q1 2026 investor letter. A copy of the letter is available to download here.
Pro-Dex’s (PDEX) Acquisition Costs Now, Gains in Future
Long Cast Advisors, an independent registered investment adviser, released its Q1 2026 investor letter. A copy of the letter is available to download here.
Long Cast Advisors Exited Enovix Corporation (ENVX) in Q1. Here’s Why
Long Cast Advisors, an independent registered investment adviser, released its Q1 2026 investor letter. A copy of the letter is available to download here.
Is NVIDIA Corporation (NVDA) One of the Best Stocks to Buy Now for Long Term Growth?
NVIDIA Corporation (NASDAQ:NVDA) is one of the best stocks to buy now for long term growth. Reuters reported on May 26 that, according to a report by Bloomberg News citing people...
AstraZeneca’s (AZN) CARES Phase III Clinical Programme Fails to Meet Primary End Point
AstraZeneca PLC (NYSE:AZN) is one of the best stocks to buy now for long term growth. AstraZeneca PLC (NYSE:AZN) reported on May 29 that the global CARES Phase III clinical programme...
Toyota Motor Corporation (TM) Seeks Approval for New Vehicle Assembly Line in Texas, Reuters Reports
Toyota Motor Corporation (NYSE:TM) is one of the best inexpensive stocks to invest in right now. Reuters reported on May 14 that Toyota Motor Corporation (NYSE:TM) has sought...
TD Securities Remains Bullish on Royal Bank of Canada (RY)
Royal Bank of Canada (NYSE:RY) is one of the best inexpensive stocks to invest in right now. TD Securities lifted the price target on Royal Bank of Canada (NYSE:RY) to C$272 ...
CIBC Lifts PT on The Toronto-Dominion Bank (TD)
The Toronto-Dominion Bank (NYSE:TD) is one of the best inexpensive stocks to invest in right now. On May 29, CIBC lifted the price target on The Toronto-Dominion Bank (NYSE:TD...
Gilead Sciences (GILD) Announces New Results From a Post Hoc Analysis
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best inexpensive stocks to invest in right now. Gilead Sciences, Inc.
Merck & Co. (MRK) Announces Quarterly Dividend
Merck & Co., Inc. (NYSE:MRK) is one of the best inexpensive stocks to invest in right now. Merck & Co., Inc.
Here’s What Analysts Are Saying About Salesforce (CRM)
Salesforce, Inc. (NYSE:CRM) is one of the best inexpensive stocks to invest in right now. Salesforce, Inc.
Is Sandisk Corporation (SNDK) One of the Best Inexpensive Stocks to Invest in Right Now?
Sandisk Corporation (NASDAQ:SNDK) is one of the best inexpensive stocks to invest in right now. On May 28, Mizuho lifted the price target on Sandisk Corporation (NASDAQ:SNDK) ...
Is The Walt Disney Company (DIS) One of the Best Inexpensive Stocks to Invest in Right Now?
The Walt Disney Company (NYSE:DIS) is one of the best inexpensive stocks to invest in right now.
Long Cast Advisors’ Q1 2026 Investor Letter
Long Cast Advisors, an independent registered investment adviser, released its Q1 2026 investor letter.
Is Micron Technology (MU) One of the Best Inexpensive Stocks to Invest in Right Now?
Micron Technology, Inc. (NASDAQ:MU) is one of the best inexpensive stocks to invest in right now. Micron Technology, Inc.
Is Pfizer Inc. (PFE) Expanding Its Cancer Pipeline Through a Landmark Innovent Partnership?
TheFly reported on May 27 that PFE and Innovent Biologics announced a global strategic licensing and collaboration agreement covering the research and development of 12 early-...
Is Sanofi (SNY) Approaching a Breakthrough in Rare Neurological Disease Treatment?
TheFly reported on May 27 that the US Food and Drug Administration (FDA) has granted priority review to SNY’s New Drug Application for venglustat, an investigational oral glucosylceramide...
Gilead Sciences, Inc. (GILD) Gains Attention as Livdelzi Demonstrates Long-Term Efficacy and Safety
TheFly reported on May 27 that GILD presented long-term interim findings from the ongoing Phase 3 ASSURE study of Livdelzi at the 2026 European Association for the Study of ...
GSK plc (GSK) Launches Ask2BSure Meningitis Awareness Campaign With Celebrity Advocates
TheFly reported on May 7 that GSK launched a public health awareness initiative under its Ask2BSure campaign, introducing Julie Bowen and Ty Burrell as campaign advocates to promote...
Why Zoetis Inc. (ZTS) Was Downgraded Following Steep Market Selloff?
TheFly reported on May 27 that Argus downgraded ZTS from Buy to Hold following a sharp decline in the company’s share price, including a steep one-day drop of about 22% and ...
Why Canaccord Reduced Prestige Consumer Healthcare Inc. (PBH) Price Target After Q4 Weakness
We recently compiled a list of the 11 Most Undervalued Pharma Stocks to Invest In. Prestige Consumer Healthcare Inc.
Amphastar Pharmaceuticals, Inc. (AMPH) Price Target Cut to $21 At Piper Sandler Amid Pipeline Uncertainty
TheFly reported on May 11 that Piper Sandler reduced its price target on AMPH from $25 to $21 while maintaining a Neutral stance on the stock following the company’s quarterly...
Grifols, S.A. (GRFS) Sees Strong Biopharma Growth Led by Gamunex and Yimmugo
Earlier on May 7, Grifols, S.A. (NASDAQ:GRFS) reported its results for the first quarter of 2026.
Is Novo Nordisk A/S (NVO) Expanding Its Lead in Diabetes and Weight Loss Ahead of ADA Conference?
TheFly reported on May 27 that NVO announced that it will present new clinical findings from its cardiometabolic portfolio at the 2026 Scientific Sessions of the American Diabetes...
BlackLine (BL) Slid Along with Broader Software Selloff
Jackson Peak Capital, an investment management firm, released its first-quarter 2026 investor letter.
Jackson Peak Capital Remains Confident in EchoStar (SATS)
Jackson Peak Capital, an investment management firm, released its first-quarter 2026 investor letter.
Salesforce (CRM) Shows Narrative Divergence Amid Anthropic’s Developments
Jackson Peak Capital, an investment management firm, released its first-quarter 2026 investor letter.
Is Ironwood Pharmaceuticals, Inc. (IRWD) Strengthening Its Growth Outlook With Expanded Pediatric Approval for Linzess?
We recently compiled a list of the 11 Most Undervalued Pharma Stocks to Invest In. Ironwood Pharmaceuticals, Inc.
Why HUTCHMED (China) Limited (HCM) Is Gaining Attention After China Biotech Re-Rating
TheFly reported on May 28 that Morgan Stanley upgraded HCM to Equal Weight from Underweight and set a new price target of $13.60, slightly below the prior $13.75 level.
Evaluating Zoom Zoom Communications’ (ZM) Q1 Performance
Jackson Peak Capital, an investment management firm, released its first-quarter 2026 investor letter.
Is FibroBiologics, Inc. (FBLG) Advancing Toward a Breakthrough Psoriasis Treatment With CYPS317 Data?
TheFly reported on May 22 that FBLG released preclinical findings from its CYPS317 psoriasis program at the Society for Investigative Dermatology 2026 Annual Meeting.
TScan Therapeutics, Inc. (TCRX) Reports Q1 2026 Results With Improved Net Loss
TheFly reported on May 6 that TCRX announced its first-quarter 2026 financial results, covering the period ended March 31, 2026, along with a corporate update.
Why Lucid Diagnostics Inc. (LUCD) Faced a Price Target Reduction After Q1 Results
TheFly reported on May 15 that Maxim Group reduced its price target on LUCD from $3 to $2 while maintaining a Buy rating following a weaker-than-expected first-quarter revenue...
Is Expensify, Inc. (EXFY) Strengthening Its Expense Ecosystem Through New VAT Reclaim Partnership?
TheFly reported on May 21 that EXFY announced a new integration with VAT IT, a global provider of VAT reclaim services, expanding its expense management ecosystem.
GoPro, Inc. (GPRO) Stock Focus Shifts to Diversification Beyond Action Cameras
TheFly reported on May 26 that GPRO and Dive with Buddy introduced GoPro Escapes, a new travel initiative focused on curated diving experiences led by creators and professionals...
Quince Therapeutics Inc. (QNCX) Presents Positive Phase 2a Data for LAM-001 Inhaled Therapy
TheFly reported that QNCX presented Phase 2a clinical results for LAM-001 on May 18, at the American Thoracic Society conference in Orlando, evaluating an inhaled rapamycin formulation...
Why PMV Pharmaceuticals, Inc. (PMVP) Faces Funding Concerns Despite Positive Trial Activity
We recently compiled a list of the 10 Popular Penny Stocks on Robinhood to Watch in 2026. PMV Pharmaceuticals, Inc.
Is Cognition Therapeutics, Inc. (CGTX) Moving Closer to a Registrational Trial in Dementia With Lewy Bodies?
We recently compiled a list of the 10 Popular Penny Stocks on Robinhood to Watch in 2026. Cognition Therapeutics, Inc.
Is ESS Tech, Inc. (GWH) Still a Buy After Softer Q1 Results and Lower Price Target?
We recently compiled a list of the 10 Popular Penny Stocks on Robinhood to Watch in 2026. ESS Tech, Inc.
Is Takeda Pharmaceutical Company Limited (TAK) Facing Major Legal Risk After U.S. Jury Rules on Generic Drug Delay?
We recently compiled a list of the 8 Best Immunology Stocks to Buy According to Hedge Funds.
Is Twist Bioscience Corporation (TWST) a Strong Buy After Guggenheim Lifts Price Target?
TheFly reported on May 5 that a Guggenheim analyst increased the price target on TWST from $55 to $60 while maintaining a Buy rating on the stock.
Is Kymera Therapeutics, Inc. (KYMR) a Long-Term Biotech Winner After New Buy Rating and Coverage Launch At Canaccord?
We recently compiled a list of the 8 Best Immunology Stocks to Buy According to Hedge Funds. Kymera Therapeutics, Inc.
MoonLake Immunotherapeutics (MLTX) Price Target Raised to $45 At H.C. Wainwright on FDA Progress
TheFly reported on May 11 that H.C. Wainwright increased its price objective on MLTX to $45 from $40 while reaffirming a Buy rating on the stock.
UBS Lifts Valuation On Moderna, Inc. (MRNA) Ahead of Key Pipeline Catalysts
TheFly reported earlier this month, on May 4, that UBS increased its price objective on MRNA to $45 from $36 while continuing to hold a Neutral stance on the stock.
Is AbbVie Inc. (ABBV) Expanding Its Oncology Pipeline With New BPDCN Treatment Approval?
TheFly reported on May 27 that ABBV announced FDA approval of DECNUPAZ (pivekimab sunirine-pvzy) for adults diagnosed with blastic plasmacytoid dendritic cell neoplasm (BPDCN), ...
Jackson Peak Capital’s Thesis for Comfort Systems (FIX) is Getting Validated
Jackson Peak Capital, an investment management firm, released its first-quarter 2026 investor letter.
Is Merck & Co., Inc. (MRK) Expanding KEYTRUDA’s Reach With New EU Approval Momentum?
TheFly reported on May 22 that MRK announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use issued a positive recommendation supporting ...
Is Eli Lilly and Company (LLY) Expanding Into Next-Gen Vaccines With $1.55B Acquisition?
TheFly reported on May 26 that LLY agreed to acquire Vaccine Company, Inc., a clinical-stage biotech focused on in vivo nanoparticle vaccine technology designed to mimic virus...
Hedge Fund Resource Center
